The 5-lipoxygenase-activating protein (FLAP) inhibitor, MK886, induces apoptosis independently of FLAP

Biochemical Journal

Volumn 340, Issue 2, 1999, Pages 371-375

  Datta, Kaushik ^a   Biswal, Shyam S ^a   Kehrer, James P ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Antioxidants; Apoptosis; Bax; Bcl x(L)

Indexed keywords

3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 (2 QUINOLINYLMETHOXY) 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; 3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; ANTIOXIDANT; ANTISENSE OLIGONUCLEOTIDE; ARACHIDONATE 5 LIPOXYGENASE; CELL PROTEIN; FATTY ACID; LIPOXYGENASE INHIBITOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVITY; FATTY ACID OXIDATION; FLUORESCENCE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TIME;

ACETYLCYSTEINE; APOPTOSIS; BASE SEQUENCE; CARRIER PROTEINS; HUMANS; INDOLES; LIPOXYGENASE INHIBITORS; MEMBRANE PROTEINS; OLIGONUCLEOTIDES, ANTISENSE; QUINOLINES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED;

EID: 0033153192     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/0264-6021:3400371     Document Type: Article

References (38)

1. Cummings, M. C., Winterford, C. M. and Walker, N. I. (1997) Am. J. Surg. Pathol. 21, 88-101
2. Uren, A. G. and Vaux, D. L. (1996) Pharmacol. Ther. 72, 37-50
3. Nagata, S. (1997) Cell 88, 355-365
4. Sarafian, T. A. and Bredesen, D. E. (1994) Free Radicals Res. 21, 1-8
5. Sandstrom, P. A. and Buttke, T. M. (1994) J. Leukoc. Biol. 55, 221-226
6. Payne, C. M., Bernstein, C. and Bernstein, H. (1995) Leukocyte Lymph. 19, 43-93
7. Slater, A. F. G., Stefan, C., Nobel, I., van den Dobbelsteen, D. J. and Orrenius, S. (1996) Cell Death Differ. 3, 57-62
8. Maccarrone, M., Catani, M. V., Agro, A. F. and Melino, G. (1997) Cell Death Differ. 4, 396-402
9. Sandstrom, P. A., Pardi, D., Tebbey, P. W., Dudek, R. W., Terrian, D. M., Folks, T. M. and Buttke, T. M. (1995) FEBS Lett 365, 66-70
10. Ramakrishnan, N., Kalinich, J. F. and McClain, D. E. (1996) Biochem. Pharmacol. 51, 1443-1451
11. Sandstrom, P. A., Tebbey, P. W., Van Cleave, S. and Buttke, T. M. (1994) J. Biol. Chem. 269, 798-801
12. Tang, D. G., Chen, Y. Q. and Honn, K. V. (1996) Proc. Natl. Acad. Sci. U.S.A. 93, 5241-5246
13. Anderson, K. M., Levin, J., Jajeh, A., Seed, T. and Harris, J. E. (1993) Prostaglandins Leukotrienes Essent. Fatty Acids 48, 323-326
14. Anderson, K. M., Seed, T., Plate, J. M. D., Jajeh, A., Meng, J. and Harris, J. E. (1995) Leukaemia Res. 19, 789-801
15. Avis, I. M., Jett, M., Boyle, T., Vos, M. D., Moody, T., Treston, A. M., Martinez, A. and Mulshine, J. L. (1996) J. Clin. Invest. 97, 806-813
16. Buyn, T., Dudeja, P., Harris, J. E., Ou, D., Seed, T., Sawlani, D., Meng, J., Bonomi, P. and Anderson, K. M. (1997) Prostaglandins Leukotrienes Essent. Fatty Acids 56, 69-77
17. Li, Y., Maher, P. and Schubert, D. (1997) Neuron 19, 453-463
18. Wagenknecht, B., Gulbins, E., Lang, F., Dichgans, J. and Weller, M. (1997) FEBS Lett. 409, 17-23
19. Variags, D. M., Larsson, P., Feltenmark, S., Jakobsson, P.-J., Orrenius, S., Claesson, H.-E. and Aguilar-Santelises, M. (1997) Cell Death Differ. 4, 479-486
20. Dittmann, K. H., Mayer, C., Rodemann, H. P., Petrides, P. E. and Denzlinger, C. (1998) Leukaemia Res. 22, 49-53
21. Ghosh, J. and Myers, C. E. (1998) Proc. Natl. Acad. Sci. U.S.A. 95, 13182-13187
22. Datta, K., Biswal, S. S., Xu, J., Towndrow, K. M., Feng, X. and Kehrer, J. P. (1998) J. Biol. Chem. 273, 28163-28169
23. Vickers, P. J. (1995) J. Lipid Mediators Cell Signalling 12, 185-194
24. Mohammad, R. M., Mohamed, A. N., Hamdan, M. Y., Vo, T., Chen, B., Katato, K., Abubakr, Y. A., Dugan, M. C. and al-Katib, A. (1996) Leukemia 10, 130-137
25. Lee, J. C., Hapel, A. J. and Ihle, J. N. (1982) J. Immunol. 128, 2393-2398
26. Lowry, O. H., Rosebrough, N. J., Farr, A. L. and Randall, R. J. (1951) J. Biol. Chem. 193, 265-275
27. Duke, R. C. and Cohen, J. J. (1992) in Current Protocols in Immunology (Coligan, J. E. and Kruisbeak, A. M., eds.), pp. 3.17.1-3.17.6, John Wiley and Sons, New York
28. Salgame, P., Varadhachary, A. S., Primiano, L. L., Fincke, J. E., Muller, S. and Monestier, M. (1997) Nucleic Acids Res. 25, 680-681
29. Claesson, H.-K., Jakobsson, P.-J., Steinhilber, D., Odlander, B. and Samuelsson, B. (1993) J. Lipid Mediators 6, 15-22
30. Kargman, S., Rousseau, P., Reid, G. K., Rouzer, C. A., Mancini, J. A., Rands, E., Dixon, R. A. F., Diehl, R. E., Léveillé, C., Nathaniel, D. et al. (1993) J. Lipid Mediators 7, 31-45
31. el Makhour-Hojeij, Y., Baclet, M. C., Chable-Rabinovitch, H., Beneytout, J. L. and Cook, J. (1994) Prostaglandins 48, 21-29
32. Battu, S., Beneytout, J. L., Pairet, M. and Rigaud, M. (1998) FEBS Lett. 437, 49-55
33. Mancini, J. A., Abramovitz, M., Cox, M. E., Wong, E., Charleson, S., Perrier, H., Wang, Z., Prasit, P. and Vickers, P. J. (1993) FEBS Lett. 318, 277-281
34. Glatz, J. F. C., Vork, M. M., Cistola, D. P. and Van der Vusse, G. J. (1993) Prostaglandins Leukotrienes Essent. Fatty Acids 48, 33-41
35. Glatz, J. F. C., Borchers, T., Spener, F. and Van der Vusse, G. J. (1995) Prostaglandins Leukotrienes Essent. Fatty Acids 52, 121-127
36. Glatz, J. F. C., van Nieuwenhoven, F. A., Luiken, J. J. F. P., Schaap, F. G. and van der Vusse, G. J. (1997) Prostaglandins Leukotrienes Essent. Fatty Acids 7, 373-378
37. Koller, M., Wachtler, P., David, A., Muhr, G. and Konig, W. (1997) Inflammation 21, 463-474
38. Brideau, C., Chan, C., Charleson, S., Denis, D., Evans, J. F., Ford-Hutchinson, A. W., Fortin, R., Gillard, J. W., Guay, J., Guévremont, D. et al. (1992) Can. J. Physiol. Pharmacol. 70, 799-807